Literatur
WHO – State of the art of new vaccines Research & Development. Initiative for vaccine research. Geneva, April 2003
Giaquinto C et al (2006) Burden of pediatric rotavirus gastroenteritis at hospital and primary care levels in seven European countries: results from REVEAL study (Rotavirus gastroenteritis epidemiology and viral types in Europe accounting for losses in public health and society). Abstract
Glass RI, Gentsch J, Smith JC (1994) Rotavirus vaccines: success by reassortment? Science 265: 1389–1391
Glass RI, Gentsch JR, Ivanoff B (1996) New lessons for rotavirus vaccines. Science 272: 46–48
Roberts L (2004) Rotavirus vaccines' second chance. Science 305: 1890–1893
Glass RI, Bresee JS, Parashar U, Turcios R, Fischer TK, Jiang B, Widdowson MA, Gentsch J (2005) Rotavirus vaccines: past present and future. Arch Pediatr 12: 844–847
Grimwood K, Abbott GD, Fergusson DM, Jennings LC, Allan JM (1983) Spread of rotavirus within families: a community based study. Br Med J (Clin Res Ed) 287: 575–577
Waters V, Ford-Jones EL, Petric M, Fearon M, Corey P, Moineddein R (2000) Etiology of community aquired pediatric viral diarrhoea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus ourbreak, 1997–1998. Pediatric Infect Dis J 19: 843–848
Rendi-Wagner P, Kundi M, Mikolasek A, Mutz I, Zwiauer K, Wiedermann U, Vecsei A, Kollaritsch H (2006) Active hospital based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003. Wien Klin Wochenschr 118: 280–285
Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15: 29–56
Vesikari T, Clark HF, Offit RA et al (2004) The effect of dose and composition of a pentavalent roatvirus vaccine (RotaTeq®) upon safety, efficacy and immunogenicity in healthy infants. 22nd annual meeting of the European Society for Pediatric Infectious Diseases (ESPID), Tampere, Finland, May 26–28, 2004
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team (2006) Safety and Efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23–33
Österreichischer Impfplan 2007 vom 21. November 2006, www.bmfg.gv.at
Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P (2004) Safety, efficacy and immunogenicity in healthy infants. J Pediatr 144: 184–190
SPMSD, Data on file 2004
Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM; Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study Group (2007) Efficacy, immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 119: 11–18
Center for Disease Control and Prevention (1999) Intussusception among recipients of rotavirus vaccine United States, 1998–1999. MMWR Morb Mortal Wkly Rep 48: 577–781
Center for Disease Control and Prevention (1999) Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 48: 1007
Rights and permissions
About this article
Cite this article
Höhl, R. Impfplan 2007 – Details zur Rotavirusimpfung. Wien Med Wochenschr 157, 133–135 (2007). https://doi.org/10.1007/s10354-007-0401-2
Issue Date:
DOI: https://doi.org/10.1007/s10354-007-0401-2